LUCID GROUP PARTNERS WITH NEW INVESTOR ICG
March 10, 2021 | Lucid, Medical Communications, investment
Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.
Founded in 2007, Lucid Group is a strategic healthcare communications company committed to advancing patient health outcomes through healthcare communications that improve the way patients and diseases are managed, and medicines are used. Lucid Group’s pioneering approaches have received industry-wide recognition and have consistently led to above industry growth.
With offices in the UK, US and Asia, Lucid now employs around 250 people. Lucid works in partnership with the world’s leading pharmaceutical and biotech organisations and has played a pivotal role in providing healthcare communication solutions for many of the industry’s innovative blockbuster assets.
LDC will exit after nearly four successful years during which Lucid has completed two successful acquisitions – HealthCare21 and Bluedog – strengthening its digital, creative and scientific offering, expanding its high-profile client base and significantly strengthening its team and operations. Lucid also expanded internationally, launching into new markets in Singapore and Dubai and adding to its established presence in the US. These accomplishments, with LDC’s support, have enabled Lucid to reach key milestones in the first phase of its ambitious growth plans.
ICG brings deep healthcare sector expertise, a global network and significant availability of additional capital to support Lucid on its journey. ICG will support Lucid’s ambitious team to acquire and build new capabilities that will add value to its clients, attract new talent and evolve its people development offering. They will also support further expansion across geographies, with a particular focus on the US.
On securing this investment Dennis O’Brien, Lucid Group CEO, commented, “This marks the start of an exciting new chapter for Lucid, which drives increased investment to help us realise our vision of transforming lives. We have a tremendous team and a great client base, our goal is to continue to strengthen this by bringing new capabilities and more value to our partnerships. With ICG we feel we have the perfect partner who shares our vision and matches our level of ambition to transform the value we bring to our industry and to patients. ICG are deeply committed to investing in this sector and are perfectly positioned to help bring the best capabilities to our business and support us to further internationalise.”
Peter Kirtley, ICG Managing Director, commented, “ICG is a leading global alternative asset manager, with a long and successful track record of providing capital to support founder-led growing businesses like Lucid Group. We have admired Lucid Group and its reputation within the industry for many years. Through our partnership, together, we can leverage Lucid’s ambition and our sector expertise to build a truly global healthcare communications organisation.”
For more information please contact:
Laura Gaskell, Marketing Director
Email: laura.gaskell@wearelucidgroup.com
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
A Stellar Start to 2021 for Lucid Group
It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services...
Day in a #LucidLife – Meet Philippa
Ever wondered what a #LucidLife looks like?Philippa McClure, Senior Account Director, takes us through her day. We have a number of roles in client services, just like Philippa's.So, if you like what...
My Journey into Medical Writing #LucidLife
In NetworkPharma’s latest career guide for wannabe medical writers, Jane Juif, Medical Writer, discusses her unconventional journey into the world of medical communications and medical writing.My journey into Med Comms...
LUCID GROUP PARTNERS WITH NEW INVESTOR ICG
Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.Founded in...
IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO
Hey Dennis, what does this year’s IWD slogan, #ChooseToChallenge mean to you?I love it. It’s inspirational and action-oriented. It’s clear we need to change many things in our society, inequality...
Rare Disease Day in a COVID-19 environment
For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...
We Celebrate Your Whole Selves: That’s What Makes The Magic
People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...
Lucid Group: A Community of Purpose
In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to...
A magic milestone: Katherine’s 10-year workiversary
Katherine Duxbury recently celebrated the momentous and magical milestone of 10 years with Lucid Group – congratulations! Surprise virtual celebrations have been had and, while they were no replacement for...
Lucid Group – Let’s Start Talking
We can all help to transform the lives of those we touch by taking the time to talk and listen to one another. The power of conversation, sharing thoughts, worries...